Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Plum Alley Investments
company
About
Plum Alley Investments is a venture firm investing in early stage technology and healthcare companies with at least one woman founder.
- 1 - 10
Highlights
Details
- Industries
- Business Development,Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Syndicate,Venture Capital
Plum Alley Investments is a venture firm investing in early stage, high growth technology and healthcare companies with at least one woman founder from the STEM fields. Plum Alley invests in advanced technologies and medical breakthroughs disrupting huge markets and driving exponential value for people, the planet, markets and the economy. The firm invests both via the Plum Alley Venture Fund I LP as well as through Plum Alley Syndicates.As of April 30th, 2021 Plum Alley has invested over $35M across 24 companies.
Investments
Number of Investments
Number of Lead Investments
14
0
Plum Alley Investments has made 14 investments. Their most recent investment was on
Mar 11, 2022, when AiFi raised $65M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Mar 11, 2022
AiFi
|
Series B | $65M | Artificial Intelligence | — |
|
Sep 9, 2021
Mammoth Biosciences
|
Series D | $150M | Biotechnology | — |
|
Feb 24, 2021
Bitwise Industries
|
Series B | $50M | Education | — |
|
Jan 7, 2021
Air Protein
|
Series A | $32M | Biotechnology | — |
|
Nov 19, 2020
Aclima
|
Series B | $40M | Analytics | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
